Volume | 1,326,790 |
|
|||||
News | - | ||||||
Day High | 3.31 | Low High |
|||||
Day Low | 3.12 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3.31 | 3.12 | 3.31 | 3.20 | 3.34 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
7,524 | 1,326,790 | US$ 3.23 | US$ 4,287,179 | - | 1.69 - 3.64 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
06:27:16 | 25 | US$ 3.20 | USD |
Arbutus Biopharma (ABUS) Options Flow Summary
Arbutus Biopharma Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
574.38M | 179.49M | - | 18.14M | -72.85M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arbutus Biopharma News
Date | Time | Source | News Article |
---|---|---|---|
07/6/2024 | 01:16 | Edgar (US Regulatory) | Form 8-K - Current report |
07/6/2024 | 01:15 | GlobeNewswire Inc. | Treatment with Arbutus’ Imdusiran and VTP-300 Achieves.. |
05/6/2024 | 20:00 | Edgar (US Regulatory) | Form 8-K - Current report |
05/6/2024 | 16:30 | GlobeNewswire Inc. | Arbutus’ Imdusiran with Short Course Interferon Achieves.. |
29/5/2024 | 21:30 | GlobeNewswire Inc. | Arbutus to Participate in Jefferies Global Healthcare.. |
29/5/2024 | 06:25 | Edgar (US Regulatory) | Form 8-K - Current report |
25/5/2024 | 06:10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
25/5/2024 | 06:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
22/5/2024 | 20:00 | Edgar (US Regulatory) | Form 8-K - Current report |
22/5/2024 | 16:00 | GlobeNewswire Inc. | Arbutus to Present Imdusiran Data at EASL Congress 2024 |
17/5/2024 | 23:03 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
17/5/2024 | 23:00 | Business Wire | Whitefort Capital Publishes Open Letter to Arbutus Biopharma.. |
Historical ABUS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.32 | 3.64 | 3.12 | 3.45 | 1,257,470 | -0.12 | -3.61% |
1 Month | 2.96 | 3.64 | 2.7903 | 3.28 | 1,002,606 | 0.24 | 8.11% |
3 Months | 2.59 | 3.64 | 2.30 | 2.98 | 1,272,742 | 0.61 | 23.55% |
6 Months | 2.06 | 3.64 | 1.98 | 2.79 | 1,100,458 | 1.14 | 55.34% |
1 Year | 2.62 | 3.64 | 1.69 | 2.52 | 871,351 | 0.58 | 22.14% |
3 Years | 2.9787 | 6.50 | 1.69 | 3.50 | 1,921,094 | 0.2213 | 7.43% |
5 Years | 1.64 | 9.00 | 0.81 | 3.66 | 2,077,642 | 1.56 | 95.12% |